Adipose-Driven Fertility Boost
Adinizer is a breakthrough technology in regenerative and reproductive medicine — a minimally invasive system that uses your own body’s resources to restore ovarian function, enhance fertility, and support long-term wellness.
Certified by FDA, CE, and TGA, Adinizer ensures precision, safety, and clinical reliability in every procedure.
At the International Fertility Group, we merge regenerative science with advanced reproductive medicine to give every patient a second chance at parenthood.
Discover how Adinizer can help you restore ovarian vitality and renew your fertility potential — naturally and safely.
Adinizer features an ultra-sharp blade system that allows for gentle, precise extraction of adipose (fat) tissue — the body’s richest natural source of regenerative cells.
This advanced system helps isolate high-quality stromal vascular fraction (SVF) and adipose-derived stem cells (ADSCs), both known for their ability to rejuvenate and repair tissues.
Gentle harvesting minimizes discomfort, tissue trauma, and recovery time.
Operates in a completely closed system to prevent contamination or infection.
Produces a high concentration of regenerative cells enriched with growth factors to restore ovarian function and boost fertility.
Adinizer harnesses regenerative cells from your own adipose tissue to stimulate tissue repair, improve ovarian response, and enhance reproductive potential.
Adipose tissue is collected using Adinizer’s ultra-sharp blade system under local anesthesia.
This ensures minimal trauma and maximum cell viability.
The harvested fat is processed in a closed, sterile environment, isolating the stromal vascular fraction (SVF) and adipose-derived stem cells (ADSCs) — rich in regenerative potential.
The regenerative cell suspension is then injected into targeted areas, such as the ovaries, to stimulate follicular activity, improve hormone balance, and restore ovarian health.
Adinizer may be recommended for individuals experiencing:
We’ll take a close look at your hormone levels, cycle history, and goals to see if this could be the right next step for you.
Adinizer may not be suitable for patients with:
Adinizer treatments are exclusively available at IFG’s advanced center in Tirana, Albania.
Our modern facility combines precision technology, international expertise, and compassionate care — offering a safe and comfortable environment for every patient.
At the International Fertility Group, we merge regenerative science with advanced reproductive medicine to give every patient a second chance at parenthood.
Discover how Adinizer can help you restore ovarian vitality and renew your fertility potential — naturally and safely.
Reach out with any questions or concerns.
Fields marked with an asterisk are required.
Adinizer ovarian therapy is a regenerative fertility treatment considered for patients facing diminished ovarian reserve, low AMH, poor IVF response, or those exploring ovarian function restoration before continuing with fertility treatment. International Fertility Group (IFG) helps patients understand whether Adinizer fertility treatment is a relevant option for their situation, coordinating access to this approach through qualified reproductive specialists and a structured medical evaluation process.
Determining whether Adinizer ovarian rejuvenation is appropriate begins with a thorough review of each patient's hormone levels, cycle history, IVF response, ovarian reserve, and overall fertility goals. IFG works with patients to assess this picture clearly before any treatment decisions are made, connecting them with specialists who can evaluate the case and explain what this regenerative approach may offer in their specific medical context. The focus is on informed decision–making rather than a generalized pathway that doesn't account for individual circumstances.
Adinizer is rooted in regenerative medicine, using adipose–derived regenerative cells, including stromal vascular fraction and ADSCs, to support ovarian reserve restoration therapy and ovarian function at a cellular level. As an ovarian regeneration therapy, it represents a different category of intervention from hormone–based or surgical approaches, aimed at supporting the biological environment rather than replacing it. IFG coordinates access to this treatment as part of a broader regenerative fertility treatment offering, with each case evaluated individually before a protocol is recommended.
The suitability and cost of Adinizer ovarian therapy depend on a range of factors: the patient's age, hormonal indicators, ovarian reserve, IVF history, the need for additional procedures, and the country where treatment takes place. IFG does not offer fixed pricing or guaranteed outcomes, as both depend on individual medical circumstances that vary from one patient to another. What patients receive is a transparent consultation, an honest medical assessment, and a realistic picture of what the Adinizer reproductive rejuvenation method would involve in their case before any commitments are made.